Global Diabetes Supplements Market Size, Status and Forecast 2024-2034
Global Diabetes Supplements Scope and Market Size
Diabetes Supplements market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.
Segment by Type
By Supplements Type
Vitamins
Minerals
Herbs
Proteins
Dietary Fibers
Others
By Dosage Form
Tablets
Capsules
Powders
Soft Gels
Liquids
Others
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Novo Nordisk
Nestlé Health Science
Danone Nutricia
NaturoGain
Nature's Sunshine Forms
Nature's Bounty
Glucose Health, Inc
Unilever(Horlicks Cardia +)
Bionova Lifesciences
Caelus Health
Abbott
Pfizer
Arkopharma Laboratories
GlaxoSmithKline
Archer Daniels Midland
Herbalife International
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Supplements Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vitamins
1.2.3 Minerals
1.2.4 Herbs
1.2.5 Proteins
1.2.6 Dietary Fibers
1.2.7 Others
1.3 Market by Application
1.3.1 Global Diabetes Supplements Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Supplements Market Perspective (2016-2027)
2.2 Diabetes Supplements Growth Trends by Regions
2.2.1 Diabetes Supplements Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Supplements Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Supplements Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Supplements Industry Dynamic
2.3.1 Diabetes Supplements Market Trends
2.3.2 Diabetes Supplements Market Drivers
2.3.3 Diabetes Supplements Market Challenges
2.3.4 Diabetes Supplements Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Supplements Players by Revenue
3.1.1 Global Top Diabetes Supplements Players by Revenue (2016-2021)
3.1.2 Global Diabetes Supplements Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Supplements Revenue
3.4 Global Diabetes Supplements Market Concentration Ratio
3.4.1 Global Diabetes Supplements Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Supplements Revenue in 2020
3.5 Diabetes Supplements Key Players Head office and Area Served
3.6 Key Players Diabetes Supplements Product Solution and Service
3.7 Date of Enter into Diabetes Supplements Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Supplements Breakdown Data by Type
4.1 Global Diabetes Supplements Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Supplements Forecasted Market Size by Type (2022-2027)
5 Diabetes Supplements Breakdown Data by Distribution Channel
5.1 Global Diabetes Supplements Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Diabetes Supplements Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Diabetes Supplements Market Size (2016-2027)
6.2 North America Diabetes Supplements Market Size by Type
6.2.1 North America Diabetes Supplements Market Size by Type (2016-2021)
6.2.2 North America Diabetes Supplements Market Size by Type (2022-2027)
6.2.3 North America Diabetes Supplements Market Size by Type (2016-2027)
6.3 North America Diabetes Supplements Market Size by Distribution Channel
6.3.1 North America Diabetes Supplements Market Size by Distribution Channel (2016-2021)
6.3.2 North America Diabetes Supplements Market Size by Distribution Channel (2022-2027)
6.3.3 North America Diabetes Supplements Market Size by Distribution Channel (2016-2027)
6.4 North America Diabetes Supplements Market Size by Country
6.4.1 North America Diabetes Supplements Market Size by Country (2016-2021)
6.4.2 North America Diabetes Supplements Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Diabetes Supplements Market Size (2016-2027)
7.2 Europe Diabetes Supplements Market Size by Type
7.2.1 Europe Diabetes Supplements Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Supplements Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Supplements Market Size by Type (2016-2027)
7.3 Europe Diabetes Supplements Market Size by Distribution Channel
7.3.1 Europe Diabetes Supplements Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Diabetes Supplements Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Diabetes Supplements Market Size by Distribution Channel (2016-2027)
7.4 Europe Diabetes Supplements Market Size by Country
7.4.1 Europe Diabetes Supplements Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Supplements Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Supplements Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Supplements Market Size by Type
8.2.1 Asia-Pacific Diabetes Supplements Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Supplements Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Supplements Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel
8.3.1 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Diabetes Supplements Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Diabetes Supplements Market Size by Region
8.4.1 Asia-Pacific Diabetes Supplements Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Supplements Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Supplements Market Size (2016-2027)
9.2 Latin America Diabetes Supplements Market Size by Type
9.2.1 Latin America Diabetes Supplements Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Supplements Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Supplements Market Size by Type (2016-2027)
9.3 Latin America Diabetes Supplements Market Size by Distribution Channel
9.3.1 Latin America Diabetes Supplements Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Diabetes Supplements Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Diabetes Supplements Market Size by Distribution Channel (2016-2027)
9.4 Latin America Diabetes Supplements Market Size by Country
9.4.1 Latin America Diabetes Supplements Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Supplements Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Supplements Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Supplements Market Size by Type
10.2.1 Middle East & Africa Diabetes Supplements Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Supplements Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Supplements Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel
10.3.1 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Diabetes Supplements Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Diabetes Supplements Market Size by Country
10.4.1 Middle East & Africa Diabetes Supplements Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Supplements Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Diabetes Supplements Introduction
11.1.4 Novo Nordisk Revenue in Diabetes Supplements Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Nestlé Health Science
11.2.1 Nestlé Health Science Company Details
11.2.2 Nestlé Health Science Business Overview
11.2.3 Nestlé Health Science Diabetes Supplements Introduction
11.2.4 Nestlé Health Science Revenue in Diabetes Supplements Business (2016-2021)
11.2.5 Nestlé Health Science Recent Development
11.3 Danone Nutricia
11.3.1 Danone Nutricia Company Details
11.3.2 Danone Nutricia Business Overview
11.3.3 Danone Nutricia Diabetes Supplements Introduction
11.3.4 Danone Nutricia Revenue in Diabetes Supplements Business (2016-2021)
11.3.5 Danone Nutricia Recent Development
11.4 NaturoGain
11.4.1 NaturoGain Company Details
11.4.2 NaturoGain Business Overview
11.4.3 NaturoGain Diabetes Supplements Introduction
11.4.4 NaturoGain Revenue in Diabetes Supplements Business (2016-2021)
11.4.5 NaturoGain Recent Development
11.5 Nature's Sunshine Forms
11.5.1 Nature's Sunshine Forms Company Details
11.5.2 Nature's Sunshine Forms Business Overview
11.5.3 Nature's Sunshine Forms Diabetes Supplements Introduction
11.5.4 Nature's Sunshine Forms Revenue in Diabetes Supplements Business (2016-2021)
11.5.5 Nature's Sunshine Forms Recent Development
11.6 Nature's Bounty
11.6.1 Nature's Bounty Company Details
11.6.2 Nature's Bounty Business Overview
11.6.3 Nature's Bounty Diabetes Supplements Introduction
11.6.4 Nature's Bounty Revenue in Diabetes Supplements Business (2016-2021)
11.6.5 Nature's Bounty Recent Development
11.7 Glucose Health, Inc
11.7.1 Glucose Health, Inc Company Details
11.7.2 Glucose Health, Inc Business Overview
11.7.3 Glucose Health, Inc Diabetes Supplements Introduction
11.7.4 Glucose Health, Inc Revenue in Diabetes Supplements Business (2016-2021)
11.7.5 Glucose Health, Inc Recent Development
11.8 Unilever(Horlicks Cardia +)
11.8.1 Unilever(Horlicks Cardia +) Company Details
11.8.2 Unilever(Horlicks Cardia +) Business Overview
11.8.3 Unilever(Horlicks Cardia +) Diabetes Supplements Introduction
11.8.4 Unilever(Horlicks Cardia +) Revenue in Diabetes Supplements Business (2016-2021)
11.8.5 Unilever(Horlicks Cardia +) Recent Development
11.9 Bionova Lifesciences
11.9.1 Bionova Lifesciences Company Details
11.9.2 Bionova Lifesciences Business Overview
11.9.3 Bionova Lifesciences Diabetes Supplements Introduction
11.9.4 Bionova Lifesciences Revenue in Diabetes Supplements Business (2016-2021)
11.9.5 Bionova Lifesciences Recent Development
11.10 Caelus Health
11.10.1 Caelus Health Company Details
11.10.2 Caelus Health Business Overview
11.10.3 Caelus Health Diabetes Supplements Introduction
11.10.4 Caelus Health Revenue in Diabetes Supplements Business (2016-2021)
11.10.5 Caelus Health Recent Development
11.11 Abbott
11.11.1 Abbott Company Details
11.11.2 Abbott Business Overview
11.11.3 Abbott Diabetes Supplements Introduction
11.11.4 Abbott Revenue in Diabetes Supplements Business (2016-2021)
11.11.5 Abbott Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Details
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Diabetes Supplements Introduction
11.12.4 Pfizer Revenue in Diabetes Supplements Business (2016-2021)
11.12.5 Pfizer Recent Development
11.13 Arkopharma Laboratories
11.13.1 Arkopharma Laboratories Company Details
11.13.2 Arkopharma Laboratories Business Overview
11.13.3 Arkopharma Laboratories Diabetes Supplements Introduction
11.13.4 Arkopharma Laboratories Revenue in Diabetes Supplements Business (2016-2021)
11.13.5 Arkopharma Laboratories Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Details
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Diabetes Supplements Introduction
11.14.4 GlaxoSmithKline Revenue in Diabetes Supplements Business (2016-2021)
11.14.5 GlaxoSmithKline Recent Development
11.15 Archer Daniels Midland
11.15.1 Archer Daniels Midland Company Details
11.15.2 Archer Daniels Midland Business Overview
11.15.3 Archer Daniels Midland Diabetes Supplements Introduction
11.15.4 Archer Daniels Midland Revenue in Diabetes Supplements Business (2016-2021)
11.15.5 Archer Daniels Midland Recent Development
11.16 Herbalife International
11.16.1 Herbalife International Company Details
11.16.2 Herbalife International Business Overview
11.16.3 Herbalife International Diabetes Supplements Introduction
11.16.4 Herbalife International Revenue in Diabetes Supplements Business (2016-2021)
11.16.5 Herbalife International Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details